Sanofi India Limited — Important, 22-01-2025: General Updates

Sanofi India has received a Transfer Pricing order from the Income Tax Department, which disallows certain international transactions for the assessment year 2022-23. The total income tax liability cited in the order amounts to ₹26.50 crore (cr). While the company is currently awaiting the completion of the draft assessment proceedings, it plans to appeal to higher tax authorities following this process. Despite the issuing of the order, Sanofi India has indicated that there is no material impact on its financial, operational, or other activities. Investors are encouraged to monitor this situation as it develops, considering potential implications for the company's future tax obligations.